The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour

BJU International

Volumn 94, Issue 9, 2004, Pages 1258-1262

  Solsona, Eduardo ^a,b   Iborra, Inmaculada ^a   Rubio, Jose ^a   Casanova, Juan ^a   Almenar, Sergio ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b C/O Prof Beltrán ^*  (Spain)

Author keywords

Cystectomy; High risk patients; Recurrent superficial bladder cancer; Timing of cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 11144225270     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05228.x     Document Type: Article

References (21)

1. Cookson MS, Sarosdy MF. Management of stage T1 superficial bladder cancer with intravesical bacillus of Calmette-Guerin. J Urol 1992; 148: 797-801
2. Davis JW, Sheth SI, Doviak MJ, Shellhammer PF. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free an disease specific survival with minimum 10-year followup. J Urol 2002; 167: 494-500
3. Herr HW. Risk-benefit ratio of intravesical BCG. indications for cystectomy after initial conservative approach. In Böhle A, Jocham D, eds. Optimal Therapies for Patients Wtih High-Risk Superficial Bladder Cancer: Controversy and Consensus. Vol. 37. Oxford: Medicine. Publications Foundation, 1997: 97-102
4. Solsona E, Iborra I, Dumont R, Rubio-Briones J, Casanova JL, Almenar S. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 2000; 164: 685-9
5. Amling CL, Thrasher JB, Frazier HA, Dodge RK, Robertson JE, Paulson L. Radical cystectomy for stages Ta, T1S and T1 transitional cell carcinoma of the bladder. J Urol 1994; 151: 31-6
6. Bracken RB, McDonald MW, Johnson DE. Cystectomy for superficial bladder cancer. Urology 1981; 18: 459-63
7. Freeman JA, Esrig D, Stein JP et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995; 76: 833-9
8. Malkowicz SB, Nichols P, Lieskovsky G, Boyd S, Hoffman J, Skinner DG. The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, P1S and P2). J Urol 1990; 144: 641-5
9. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75
10. Stöckle M, Alken P, Englemann U, Jacobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy - often too late? Eur Urol 1987; 13: 361-7
11. Huguet J, Palou J, Millán F, Villavicencio H, Vicente J. Cistectomia radical en tumores superficiales en la era de la BCG. Arch Esp Urol 2002; 55: 50-6
12. Siref LE, Zincke H. Radical cystectomy for historical and pathologic T1, NO, MO (Stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy? Urology 1988; 31: 309-11
13. Dalbagni G, Genega E, Hashibe M et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165: 1111-6
14. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994; 73: 1926-31
15. Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 1998; 16: 1099-102
16. Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova JL, Almenar S. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol 1995; 154: 1710-3
17. Solsona E, Iborra I, Rubio J, Casanova J, Dumont R, Monrós JL. Late occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 2003; 43: 489-94
18. Chéchile G, Sarroca J, Zungri E, Resales E, Martínez E. Place of cystectomy in superficial bladder cancer. Urol Int 1988; 43: 330-3
19. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 2002; 167: 1573-83
20. Herr HW, Badalament RA, Amato D, Laudone VP, Fair WR, Whitmore WF. Superficial bladder cancer treated with bacillus Calmette-Guerin. A multivariate analysis of factors affecting tumor progression. J Urol 1989; 141: 22-9
21. Merz VW, Marth D, Kraft R, Ackermann DK, Zingg EJ, Studer UE. Analysis of early failures after intravesical instillation therapy with bacillus Calmette-Guerin for carcinoma in situ of the bladder. Br J Urol 1995; 75: 180-4